To verify this, we evaluated LPAL2 expression in hepatoma cell lines treated with or without doxorubicin, and found that LPAL2 expression was repressed by doxorubicin treatment in HA22T and Huh7 cell lines (Figure 4B). The gene discussed is LPAL2; the disease is hepatocellular carcinoma.